Additional file 2 of SGLT2 inhibitors improve kidney function and morphology by regulating renal metabolic reprogramming in mice with diabetic kidney disease

Additional file 2: Table S1. Information of 6009 quantified proteins in renal proteomics. Table S2. Information of 1481 quantified proteins in serum proteomics. Table S3. Information of 501 and 91 DEPs identified in db/db and Empa groups in renal proteomics, respectively. Table S4. Information of 32 EAPs between Empa and db/db groups in kidney. Table S5. Information of 235 and 83 DEPs identified in db/db and Empa groups in serum proteomics, respectively. Table S6. Information of 51 EAPs between Empa and db/db groups in serums. Table S7. Information of 897 quantified metabolites in renal metabolomics. Table S8. Information of 678 quantified metabolites in serum metabolomics. Table S9. Information of 264 identified differentially expressed metabolites between db/db and db/m groups in kidney metabolomics. Table S10. Information of 174 identified differentially expressed metabolites between db/db and db/m groups in serum metabolomics. Table S11. Information of 94 Empa-altered metabolites between Empa and db/db groups in kidney. Table S12. Information of 37 Empa-altered metabolites between Empa and db/db groups in serum.

附加文件2：表S1：收录肾脏蛋白质组学中6009个定量蛋白质的相关信息。
表S2：收录血清蛋白质组学中1481个定量蛋白质的相关信息。
表S3：分别收录肾脏蛋白质组学中db/db组与Empa组鉴定得到的501个和91个差异表达蛋白（Differentially Expressed Proteins，DEPs）的相关信息。
表S4：收录肾脏组织中Empa组与db/db组间32个差异调控蛋白（Empa-altered Proteins，EAPs）的相关信息。
表S5：分别收录血清蛋白质组学中db/db组与Empa组鉴定得到的235个和83个DEPs的相关信息。
表S6：收录血清样本中Empa组与db/db组间51个EAPs的相关信息。
表S7：收录肾脏代谢组学中897个定量代谢物的相关信息。
表S8：收录血清代谢组学中678个定量代谢物的相关信息。
表S9：收录肾脏代谢组学中db/db组与db/m组间鉴定得到的264个差异表达代谢物的相关信息。
表S10：收录血清代谢组学中db/db组与db/m组间鉴定得到的174个差异表达代谢物的相关信息。
表S11：收录肾脏组织中Empa组与db/db组间94个经Empa调控的差异代谢物的相关信息。
表S12：收录血清样本中Empa组与db/db组间37个经Empa调控的差异代谢物的相关信息。